UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
| x | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended June 30, 2004
| ¨ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to .
Commission file number 000-23783
MICROMUSE INC.
(Exact name of registrant as specified in its charter)
| DELAWARE | 94-3288385 | |
| (State or other jurisdiction of incorporation or organization) |
(IRS Employer Identification No.) |
139 TOWNSEND STREET
SAN FRANCISCO, CALIFORNIA 94107
(415) 538-9090
(Address, including ZIP code, and telephone number)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨
Indicate by check mark whether the registrant is an accelerated filer (as defined in rule 12b-2 of the Exchange Act). Yes x No ¨
79,480,766 shares of Common Stock, $0.01 par value, were outstanding as of July 31, 2004
TABLE OF CONTENTS
| Page | ||||
| Item 1. |
||||
| Condensed Consolidated Balance Sheets as of June 30, 2004 and September 30, 2003 |
4 | |||
| 5 | ||||
| Condensed Consolidated Statements of Cash Flows for the nine months ended June 30, 2004 and 2003* |
6 | |||
| 7 | ||||
| * The Condensed Consolidated Statement of Operations for the three and nine months ended June 30, 2003 and the Condensed Consolidated Statement of Cash Flows for the nine months ended June 30, 2003 have been restated as described in Note 2 of Notes to Condensed Consolidated Financial Statements. |
||||
| Item 2. |
Managements Discussion and Analysis of Financial Condition and Results of Operations |
12 | ||
| Item 3. |
24 | |||
| Item 4. |
25 | |||
| Item 1. |
26 | |||
| Item 2. |
Changes in Securities, Use of Proceeds and Issuer Purchases of Equity Securities |
26 | ||
| Item 3. |
26 | |||
| Item 4. |
26 | |||
| Item 5. |
27 | |||
| Item 6. |
28 | |||
| 29 | ||||
2
This Form 10-Q includes restated financial information for certain periods indicated below that ended prior to our fiscal year that began on October 1, 2003.
The Company has restated its consolidated financial statements for the fiscal years ended September 30, 2001 and 2002 and for the quarters ended December 31, 2000 through June 30, 2003. Accordingly, the financial statements for those periods described above that have been included in the Companys previous filings with the Securities and Exchange Commission in 2003 or earlier or included in previous announcements in 2003 or earlier should not be relied upon.
The Companys Form 10-K for the fiscal year ended September 30, 2003, filed with the SEC on May 17, 2004, contains restated information for all of the above periods to which the restatement applies and other information relating to the restatement, in the Form 10-K Item 6 Selected Financial Data, Item 7 Managements Discussion and Analysis of Financial Condition and Results of Operations Restatement of Financial Statements, Notes 2 and 11 of the Notes to Consolidated Financial Statements included in Item 8, and Item 9A, Controls and Procedures.
Certain information concerning the restatement relating to the periods included in this report is contained in Part I to this Form 10-Q in Item 1, Note 2 below to the Condensed Consolidated Financial Statements (Unaudited), Item 2 Managements Discussion and Analysis of Financial Condition and Results of Operations, and Item 4, Controls and Procedures. This information should be read in conjunction with relevant information in the Companys most recent Form 10-K referred to above.
3
PART I - FINANCIAL INFORMATION
Item 1. Condensed Consolidated Financial Statements
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except per share data)
| June 30, 2004 (Unaudited) |
September 30,
|
|||||||
| ASSETS | ||||||||
| Current assets: |
||||||||
| Cash and cash equivalents |
$ | 101,432 | $ | 89,385 | ||||
| Short-term investments |
15,168 | 33,196 | ||||||
| Accounts receivable, net |
25,990 | 13,439 | ||||||
| Prepaid expenses and other current assets |
9,402 | 6,269 | ||||||
| Total current assets |
151,992 | 142,289 | ||||||
| Property and equipment, net |
5,966 | 5,976 | ||||||
| Long-term investments |
74,864 | 67,529 | ||||||
| Goodwill, net |
50,929 | 49,032 | ||||||
| Other intangible assets, net |
8,220 | 12,861 | ||||||
| $ | 291,971 | $ | 277,687 | |||||
| LIABILITIES AND STOCKHOLDERS EQUITY | ||||||||
| Current liabilities: |
||||||||
| Accounts payable |
$ | 5,741 | $ | 6,849 | ||||
| Accrued expenses |
11,082 | 9,855 | ||||||
| Accrued payroll |
12,330 | 10,532 | ||||||
| Income taxes payable |
6,328 | 6,368 | ||||||
| Deferred revenue |
46,855 | 37,567 | ||||||
| Total current liabilities |
82,336 | 71,171 | ||||||
| Deferred revenue, less current portion |
2,261 | 2,760 | ||||||
| Total liabilities |
84,597 | 73,931 | ||||||
| Stockholders equity: |
||||||||
| Preferred stock; $0.01 par value; 5,000 shares authorized; no shares issued and outstanding |
| | ||||||
| Common stock; $0.01 par value; 200,000 shares authorized; 79,517 and 78,544 shares outstanding as of June 30, 2004 and September 30, 2003, respectively |
795 | 785 | ||||||
| Additional paid-in capital |
214,873 | 210,697 | ||||||
| Treasury stock |
(2,657 | ) | (2,657 | ) | ||||
| Accumulated other comprehensive loss |
(1,577 | ) | (1,548 | ) | ||||
| Accumulated deficit |
(4,060 | ) | (3,521 | ) | ||||
| Total stockholders equity |
207,374 | 203,756 | ||||||
| $ | 291,971 | $ | 277,687 | |||||
| * | September 30, 2003 balances are derived from the audited financial statements included in the Companys 2003 Annual Report on Form 10-K. |
See accompanying notes to the condensed consolidated financial statements
4
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data)
(Unaudited)
| Three months ended June 30, |
Nine months ended June 30, |
|||||||||||||||
| 2004 |
2003 |
2004 |
2003 |
|||||||||||||
| (As Restated) | (As Restated) | |||||||||||||||
| Revenues: |
||||||||||||||||
| License |
$ | 17,690 | $ | 18,233 | $ | 58,297 | $ | 50,390 | ||||||||
| Maintenance and services |
17,135 | 14,692 | 52,002 | 42,054 | ||||||||||||
| Total revenues |
34,825 | 32,925 | 110,299 | 92,444 | ||||||||||||
| Cost of revenues: |
||||||||||||||||
| License |
1,468 | 1,251 | 4,355 | 3,335 | ||||||||||||
| Maintenance and services |
3,140 | 2,593 | 8,456 | 8,115 | ||||||||||||
| Amortization of developed technology |
1,527 | 1,053 | 4,515 | 3,089 | ||||||||||||
| Total cost of revenues |
6,135 | 4,897 | 17,326 | 14,539 | ||||||||||||
| Gross profit |
28,690 | 28,028 | 92,973 | 77,905 | ||||||||||||
| Operating expenses: |
||||||||||||||||
| Sales and marketing |
15,696 | 14,436 | 47,181 | 45,833 | ||||||||||||
| Research and development |
8,102 | 7,417 | 24,121 | 21,726 | ||||||||||||
| General and administrative |
6,684 | 3,947 | 18,528 | 12,623 | ||||||||||||
| Restatement costs |
1,616 | | 5,466 | | ||||||||||||
| Amortization of other intangible assets |
48 | 194 | 143 | 1,115 | ||||||||||||
| Restructuring costs |
| 1,655 | | 4,795 | ||||||||||||
| Total operating expenses |
32,146 | 27,649 | 95,439 | 86,092 | ||||||||||||
| Income (loss) from operations |
(3,456 | ) | 379 | (2,466 | ) | (8,187 | ) | |||||||||
| Other income, net |
1,151 | 693 | 2,865 | 3,378 | ||||||||||||
| Income (loss) before income taxes |
(2,305 | ) | 1,072 | 399 | (4,809 | ) | ||||||||||
| Income tax provision (benefit) |
181 | (144 | ) | 938 | 899 | |||||||||||
| Net income (loss) |
$ | (2,486 | ) | $ | 1,216 | $ | (539 | ) | $ | (5,708 | ) | |||||
| Per share data: |
||||||||||||||||
| Basic net income (loss) |
$ | (0.03 | ) | $ | 0.02 | $ | (0.01 | ) | $ | (0.07 | ) | |||||
| Diluted net income (loss) |
$ | (0.03 | ) | $ | 0.02 | $ | (0.01 | ) | $ | (0.07 | ) | |||||
| Weighted average shares used in computing: |
||||||||||||||||
| Basic net income (loss) per share |
78,993 | 76,635 | 78,760 | 76,577 | ||||||||||||
| Diluted net income (loss) per share |
78,993 | 80,087 | 78,760 | 76,577 | ||||||||||||
See accompanying notes to the condensed consolidated financial statements
5
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)
| Nine months ended June 30, |
||||||||
| 2004 |
2003 |
|||||||
| (As Restated) | ||||||||
| Cash flows from operating activities: |
||||||||
| Net loss |
$ | (539 | ) | $ | (5,708 | ) | ||
| Adjustments to reconcile net loss to net cash provided by operating activities: |
||||||||
| Depreciation and amortization |
7,576 | 9,178 | ||||||
| Purchased in process research & development |
| 142 | ||||||
| Non-cash stock based compensation |
553 | 54 | ||||||
| Tax benefit related to exercise of stock options |
464 | 427 | ||||||
| Changes in assets and liabilities, net of acquired amounts: |
||||||||
| Accounts receivable, net |
(12,551 | ) | 11,088 | |||||
| Prepaid expenses and other current assets |
(3,133 | ) | (736 | ) | ||||
| Accounts payable |
(1,108 | ) | 1,803 | |||||
| Accrued expenses |
3,025 | (3,714 | ) | |||||
| Income taxes payable |
(40 | ) | (479 | ) | ||||
| Deferred revenue |
8,789 | 9,470 | ||||||
| Net cash provided by operating activities |
3,036 | 21,525 | ||||||
| Cash flows from investing activities: |
||||||||
| Capital expenditures |
(2,862 | ) | (836 | ) | ||||
| Investment purchases |
(165,980 | ) | (130,252 | ) | ||||
| Investment sales |
176,672 | 77,370 | ||||||